Upstream Bio, Inc. (UPB) earnings · rev $2.9M
These earnings events as JSON? API free 100/dayUpstream Bio, Inc. (UPB) is a biotechnology company listed on US.
This UPB earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported UPB revenue for 2025-12-31 was $2.9M. Net income was -$143.4M. Revenue was up 20.4% from 2024-12-31 to 2025-12-31. UPB currently screens at market cap $407.3M.
When the next UPB 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 20.4% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full UPB research stays on the stock page; the tape stays on the quote page.
UPB earnings FAQ
What are UPB's latest revenue and net income?
Latest cached Upstream Bio, Inc. (UPB) revenue for Dec 31, 2025 was $2.9M. Net income was -$143.4M. Statements: https://lician.com/financials/upb
What is UPB's latest diluted EPS?
Latest cached Upstream Bio, Inc. (UPB) diluted EPS for Dec 31, 2025 was -$2.66.
What period does the latest UPB earnings print cover?
The latest cached Upstream Bio, Inc. (UPB) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did UPB revenue change from the prior cached period?
Cached Upstream Bio, Inc. (UPB) revenue was up 20.4% from $2.4M (Dec 31, 2024) to $2.9M (Dec 31, 2025). Statements: https://lician.com/financials/upb
Where are UPB earnings listed?
Cached earnings facts for Upstream Bio, Inc. (UPB) are listed at https://lician.com/earnings/upb. Statements: https://lician.com/financials/upb
Not investment advice.